文献速递青光眼

原发性开角型青光眼中的烟酰胺缺乏

Nicotinamide Deficiency in Primary Open-Angle Glaucoma.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2019-01-01

研究比较34例原发性开角型青光眼(POAG)患者与30例年龄性别匹配对照的血浆烟酰胺浓度,半定量法显示POAG组显著降低;靶向定量法在初始队列及20例POAG与15例对照的复制队列中均证实POAG组血浆烟酰胺浓度显著低于对照组。作者认为青光眼与较低血浆烟酰胺水平相关,提示烟酰胺补充可能成为未来治疗策略,但需更大队列进一步研究确认这些初步发现。

要点

  • 半定量法显示初始队列POAG患者血浆烟酰胺浓度显著低于年龄性别匹配对照。
  • 定量法证实初始队列POAG组均值0.14 μM,对照组0.19 μM,降低30%(P=0.022)。
  • 复制队列POAG组均值0.14 μM,对照组0.19 μM,降低33%(P=0.011)。

核心结论

  • 青光眼与较低血浆烟酰胺水平相关,提示烟酰胺补充可能成为未来治疗策略。
  • 需在更大队列中进一步研究以确认这些初步发现。

研究设计与样本

  • 初始队列纳入34例POAG个体与30例年龄和性别匹配的对照,采用液相色谱-高分辨质谱半定量法比较血浆烟酰胺浓度。
  • 随后采用基于液相色谱-质谱的独立定量法,检测同一初始队列及复制队列(20例POAG个体与15例对照)的血浆烟酰胺浓度。

主要发现

  • 半定量法显示初始队列POAG个体血浆烟酰胺浓度显著低于对照。
  • 定量法在初始队列中显示POAG组均值0.14 μM(中位数0.12 μM;范围0.06-0.28 μM),对照组均值0.19 μM(中位数0.18 μM;范围0.08-0.47 μM),POAG组降低30%(P=0.022)。
  • 定量法在复制队列中显示POAG组均值0.14 μM(中位数0.14 μM;范围0.09-0.25 μM),对照组均值0.19 μM(中位数0.21 μM;范围0.09-0.26 μM),POAG组降低33%(P=0.011)。

局限性

  • 作者指出需在更大队列中进一步研究以确认这些初步发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the plasma concentration of nicotinamide in primary open-angle glaucoma (POAG). METHODS: Plasma of 34 POAG individuals was compared to that of 30 age- and sex-matched controls using a semiquantitative method based on liquid chromatography coupled to high-resolution mass spectrometry. Subsequently, an independent quantitative method, based on liquid chromatography coupled to mass spectrometry, was used to assess nicotinamide concentration in the plasma from the same initial cohort and from a replicative cohort of 20 POAG individuals and 15 controls. RESULTS: Using the semiquantitative method, the plasma nicotinamide concentration was significantly lower in the initial cohort of POAG individuals compared to controls and further confirmed in the same cohort, using the targeted quantitative method, with mean concentrations of 0.14 μM (median: 0.12 μM; range, 0.06-0.28 μM) in the POAG group (-30%; P = 0.022) and 0.19 μM (median: 0.18 μM; range, 0.08-0.47 μM) in the control group. The quantitative dosage also disclosed a significantly lower plasma nicotinamide concentration (-33%; P = 0.011) in the replicative cohort with mean concentrations of 0.14 μM (median: 0.14 μM; range, 0.09-0.25 μM) in the POAG group, and 0.19 μM (median: 0.21 μM; range, 0.09-0.26 μM) in the control group. CONCLUSIONS: Glaucoma is associated with lower plasmatic nicotinamide levels, compared to controls, suggesting that nicotinamide supplementation might become a future therapeutic strategy. Further studies are needed, in larger cohorts, to confirm these preliminary findings.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Kouassi Nzoughet J, Chao de la Barca JM, Guehlouz K, et al. Nicotinamide Deficiency in Primary Open-Angle Glaucoma. Invest Ophthalmol Vis Sci. 2019. PMID: 31185090. doi:10.1167/iovs.19-27099

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。